Sumitomo’s Sunovion Unit Wins $18 Million in Mylan Patent Trial
February 13, 2012, 4:20 PM ESTBy Phil Milford
Feb. 10 (Bloomberg) -- Sumitomo Sumitomo Chemical Co.’s Sunovion Pharmaceuticals unit won a $18 million verdict from Mylan Inc. in a patent-infringement trial over technology for asthma-treatment inhalers.
To contact the reporter on this story: Phil Milford in Wilmington, Delaware at pmilford@bloomberg.net
To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net
